Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s traded shares stood at 1.14 million during the last session, with the company’s beta value hitting 1.49. At the close of trading, the stock’s price was $5.85, to imply a decrease of -1.35% or -$0.08 in intraday trading. The ADPT share’s 52-week high remains $6.70, putting it -14.53% down since that peak but still an impressive 61.03% since price per share fell to its 52-week low of $2.28. The company has a valuation of $863.34M, with an average of 1.25 million shares in intraday trading volume over the past 10 days and average of 1.06 million shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for Adaptive Biotechnologies Corp (ADPT), translating to a mean rating of 1.29. Of 11 analyst(s) looking at the stock, 1 analyst(s) give ADPT a Sell rating. 0 of those analysts rate the stock as Overweight while 6 advise Hold as 4 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.25.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adaptive Biotechnologies Corp (NASDAQ:ADPT) trade information
After registering a -1.35% downside in the last session, Adaptive Biotechnologies Corp (ADPT) has traded red over the past five days. The 5-day price performance for the stock is 1.74%, and 17.71% over 30 days. With these gigs, the year-to-date price performance is 19.39%. Short interest in Adaptive Biotechnologies Corp (NASDAQ:ADPT) saw shorts transact 8.96 million shares and set a 9.71 days time to cover.
The extremes give us $5 and $18 for target low and target high price respectively. As such, ADPT has been trading -207.69% off suggested target high and 14.53% from its likely low.
Adaptive Biotechnologies Corp (ADPT) estimates and forecasts
Looking at statistics comparing Adaptive Biotechnologies Corp share performance against respective industry, we note that the company has underperformed competitors. Adaptive Biotechnologies Corp (ADPT) shares are 50.00% up over the last 6 months, with its year-to-date growth rate lower than industry average at 13.77% against 17.10%. Revenue is forecast to grow 16.95% this quarter before jumping 15.28% for the next one. The rating firms project that company’s revenue will grow 4.05% compared to the previous financial year.
Revenue forecast for the current quarter as set by 5 analysts is 45.92M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 46.35M.Earnings reports from the last fiscal year show that sales brought in 45.78M and 41.87M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 0.30% before jumping 10.68% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -32.91% for the past 5-year period. While 2024 is set for a 27.93% return in earnings, projections for the next 5 years are at 21.60% annually.
ADPT Dividends
Adaptive Biotechnologies Corp has its next earnings report out in December. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Adaptive Biotechnologies Corp (NASDAQ:ADPT)’s Major holders
Adaptive Biotechnologies Corp insiders hold 1.93% of total outstanding shares, with institutional holders owning 98.91% of the shares at 100.85% float percentage. In total, 98.91% institutions holds shares in the company, led by VIKING GLOBAL INVESTORS LP. As of 2024-06-30, the company held over 29.99 million shares (or 20.5736% of shares), all amounting to roughly $108.58 million.
The next major institution holding the largest number of shares is RUBRIC CAPITAL MANAGEMENT LP with 14.0 million shares, or about 9.603% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $50.68 million.
